Symbiontics Inc.
This article was originally published in Start Up
Executive Summary
Drug Delivery; Proteins. Symbiontics hopes to use protozoa which live naturally in the human body to deliver human therapeutic proteins. The company is genetically-engineering leishmania, parasites which can cause a skin disease, to control their longevity, eliminate their pathogenicity and cause them to produce human proteins.